Month: September 2021

New York, Sept. 17, 2021 (GLOBE NEWSWIRE) —  Interpublic Group (NYSE: IPG) senior management will present at the Goldman Sachs 30th Annual Communacopia Conference on Tuesday, September 21st, 2021, at 8:50 am Eastern time, as scheduled.   A link to the live webcast will be posted on the day of the conference on the Investor Relations section of Interpublic’s website (http://investors.interpublic.com) where it will remain available for replay for 30 days. # # # About Interpublic Interpublic (NYSE: IPG) (www.interpublic.com) is a values-based, data-fueled, and creatively-driven provider of marketing solutions. Home to some of the world’s best-known and most innovative communications specialists, IPG global brands include: Acxiom, Craft, FCB, FutureBrand, Golin, Huge, Initiative, Jack Morton, Kinesso, MAGNA, Matterkind, McCann,...

Quantum Energy Inc. (QEGY) Announces Hiring of Robert Edward Murray to Lead Rare Earth Exploration, Company to Open Offices in OhioQuantum Energy Inc. (OTCPNK: QEGY) (“Quantum”) announces the hiring Robert (“Rob”) Edward Murray as Vice President of Exploration and Conservation, who will lead the Company’s rare earth exploration projects, employment is effective immediately. Quantum Energy Inc. (OTCPNK: QEGY) is an energy focused company with a project emphasis on rare earth refining, and property development in the United States and Canada. This includes the refining, processing and value-added manufacturing of rare earth elements, and other raw materials to produce magnetic and associated energy related products – www.qegy.energyHENDERSON, Nev., Sept. 17, 2021 (GLOBE NEWSWIRE) — Quantum Energy Inc. (OTCPNK:...

SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. was convened and adjourned, without any business being conducted, due to lack of the required quorum. A quorum consists of a majority of the shares entitled to vote. There were fewer than a majority of shares entitled to vote present, either in person or by proxy at this meeting. Approximately 45.6% were properly voted at the time of the annual meeting. The annual meeting of shareholders therefore had no quorum and the meeting was adjourned and will reconvene at 9:00 a.m. (Pacific Time) on Tuesday, October 5, 2021 to be held virtually at www.virtualshareholdermeeting.com/ONVO2021 to allow additional time for the Company’s shareholders...

TORONTO, Sept. 17, 2021 (GLOBE NEWSWIRE) — Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) and Fio Corporation (“Fio”) – together through their joint venture, Fionet Rapid Response Group (“FRR”) – are pleased to announce an agreement with the global IT solutions company, Unisys Corporation1(NYSE: UIS)2, for jointly marketing a combined solution, that includes FRR’s Fionet Platform for pandemic and biosecurity management, for the large, underserved biosecurity market. FRR’s Fionet Platform for pandemic and biosecurity management will be integrated with Unisys’ best-in-class U-Pass™3, which digitally authenticates individuals’ health status. This combination of Fionet mobile testing, triage, and reporting capabilities and U-Pass’ mobile authentication technologies will both increase and simplify...

MIAMI BEACH, Fla., Sept. 17, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced the closing of its previously announced initial public offering of 4,800,000 units (“Units”), with each unit consisting of one share of common stock (the “Common Stock”) and one warrant (the “Warrant”) to purchase one share of Common Stock at a public offering price of $5.00 per Unit, for aggregate gross proceeds of approximately $24.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. The Company’s Common Stock and Warrants began trading on The Nasdaq Capital Market on September 15, 2021, under the symbols “KTTA”...

SINGAPORE, Sept. 17, 2021 (GLOBE NEWSWIRE) — Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN) (JSE: GSH) (“Grindrod Shipping” or “Company” or “it” or “we”), a global provider of maritime transportation services predominantly in the drybulk sector, announced the following transactions. On September 15th, 2021, in conjunction with the previously announced acquisition of the remaining 31.14% equity stake in its IVS Bulk joint venture (“IVS Bulk”) and the concurrent redemption of the IVS Bulk preference shares on September 1, 2021, the Company closed the $23 million upsizing of one of its existing IVS Bulk credit facilities to replace the working capital used to fund the transaction. The new debt is on the same terms as the existing facility. On September 16th, 2021, the Company closed the acquisition and concurrent financing...

NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held in a virtual setting on Wednesday, September 22, 2021 at 12:25pm ET. A webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived on the Company’s website for 90 days following the presentation. About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options....

PHILADELPHIA, Sept. 17, 2021 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that it will be added to the small-cap Russell 2000® Index as a part of the 3Q21 Russell Indexes IPO additions, effective at US market open on September 20, 2021, according to the preliminary list of IPO additions to the Russell indexes. “Century’s inclusion in the Russell 2000 Index is an important milestone that reflects our continued progress toward advancing our lead therapeutic program, CNTY-101, into the clinic and to patients in need,” said Lalo Flores, Ph.D., Chief Executive Officer of Century Therapeutics. “We are pleased to join the Russell Index and look forward to sharing our potential future...

PHILADELPHIA, Sept. 17, 2021 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced it has granted inducement awards to eight newly hired employees under an inducement plan adopted by its board of directors. Passage Bio granted these employees options to purchase an aggregate of 72,000 shares as a material inducement to their employment (the Inducement Options). The Inducement Options have an exercise price of $11.50 per share, which is equal to the closing price of Passage Bio’s common stock on September 15, 2021, the grant date of the Inducement Options. The Inducement Options were granted in accordance with Nasdaq listing Rule 5635(c)(4). The shares subject to the Inducement Options...

ROSEMONT, Ill., Sept. 17, 2021 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”) (Nasdaq: WTFC) today announced it will release its third quarter and year-to-date 2021 earnings results after the market closes on Tuesday, October 19, 2021 and host a conference call on Wednesday, October 20, 2021 at 12:00 p.m. (EDT). Individuals interested in participating in the call should dial 877-363-5049 and enter Conference ID #2695417 or a simultaneous audio-only web cast may be accessed via the Company’s web site at http://www.wintrust.com, Investor Relations link. An accompanying slide presentation for those participating in the call or listening via web cast will be available on the Company’s web site at http://www.wintrust.com, Investor Relations link. A replay of the audio-only webcast and an accompanying slide...